Lundbeck sites Contact Us
In clinical studies, Ebixa has shown to be an efficacious treatment compared with placebo for moderate to severe Alzheimer's disease.
The overall frequency of patients who experienced side-effects was similar with Ebixa compared to placebo.
The Prescribing Information outlines the indications of the product, as well as specifics such as dosage, contra-indications, pregnancy and lactation, precautions, drug interactions, adverse events and overdoses.